Brain natriuretic peptide. Diagnostic value in heart failure;Péptido cerebral natriurético. Valor diagnóstico en la insuficiencia cardíaca

Revista Espanola de Cardiologia

Volumn 55, Issue 1, 2002, Pages 7-15

  Osca Asensi, Joaquín ^a   Quesada, Anastasio ^a   Arnau, Miguel A ^a   Osa, Ana ^a   Hervás, Isabel ^a   Almenar, Luis ^a   Palencia, Migeul ^a   Mateo, Antonio ^a   Algarra, Francisco ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Brain natriuretic peptide; Diagnosis; Heart Failure

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; BIOCHEMICAL MARKER; CREATININE;

ADULT; AGED; ARTICLE; BLOOD; CONGESTIVE HEART FAILURE; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; SYSTOLE; BLOOD ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC VALUE; DIASTOLE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FUNCTIONAL ASSESSMENT; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART SIZE; LUNG PRESSURE; MAJOR CLINICAL STUDY; PROGNOSIS; RADIOIMMUNOASSAY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; SYSTOLE;

EID: 0036007864     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-8932(02)76547-0     Document Type: Article

References (45)

1. Guidelines for the diagnosis of heart failure
2. The role of neurohormonal activation in chronic heart failure and postmyocardial infarction
3. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality
4. Prognostic value of neurohormonal activation in patients with an acute myocardial infarction; effect of captopril
5. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats
6. A new natriuretic peptide in porcine brain
7. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide
8. Isolation and sequence determination of human brain natriuretic peptide in human atrium
9. Renal, endocrine, and hemodynamic interactions of atrial and brain natriuretic peptides in normal men
10. Effect of BNP on renal hemodynamics, tubular function and vasoactive hormones in humans
11. Measurement and significance of circulating natriuretic peptides in cardiovascular disease
12. Review of 10 years of the clinical use of brain natriuretic peptide in cardiology
13. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern
14. Natriuretic peptides: Physiology, therapeutic potential, and risk stratification in ischemic heart disease
15. Biochemical detection of left-ventricular systolic dysfunction
16. Value of natriuretic peptides in assessment os patients with possible new heart failure in primary care
17. Plasma N-probrain natriuretic peptide and adrenomedullin. New neurohumoral predictors of left ventricular function and prognosis after myocardial infarction
18. Detection of left ventricular dysfunction after acute myocardial infarction: Comparison of clinical, echocardiographic, and neurohumoral methods
19. Plasma brain natriretic peptide in assesment of acute dyspnoea
20. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction
21. Different secretion Patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure
22. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: Influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation
23. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction
24. Comparison of secretion pattern between A-type and B-type natriuretic peptides in patients with old myocardial infarction
25. Plasma brain natriuretic peptide is a biochemical marker for the prediction of preogressive ventricular remodeling after acute myocardial infaction
26. Sustained elevation of plasma brain natriuretic peptide levels associated with progressive ventricular remodeling after acute myocardial infarction
27. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure. Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction
28. BNP: Increasing importance in the pathophysiology and diagnosis of congestive heart failure
29. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and peptide
30. Brain natriuretic peptide predicts mortality in the elderly
31. Guías de actuación clínica para el diagnóstico y manejo de la insuficiencia cardíaca y shock cardiogénico
32. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction
33. Evidence of improving prognosis in heart failure. Trends in case fatality in 66547 patients hospitalized between 1986 and 1995
34. Survival after the onset of congestive heart failure in Framingham Heart Study subjects
35. Prevalence and mortality rate of congestive heart failure in the United States
36. The epidemiology of heart failure
37. Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic disfunction in a high risk population
38. Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients
39. Increased plasma levels of brain natriuretic peptide in patients with isolated distolic dysfunction
40. Cohort study of plasma natriuretic peptides for identifying left ventricular systolic disfunction in primary care
41. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction
42. Effects of angiotensin-converting enzyme inhibitor on plasma B-type natriuretic peptide levels in patients with acute myocardial infarction
43. Digitalis increases brain natriretic peptide in patients with severe congestive heart failure
44. Effect of low dose beta blockers on atrial and ventricular (B type) natriuretic factor in heart failure: A double blind, randomized comparison of metoprolol and a third generation vasodilating beta-blocker
45. Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: Implications for clinical practice